| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
18,933 | 18,634 | 17,026 | 14,928 | 12,766 | 11,470 | 9,614 | 7,767 | 5,706 |
Cost of goods sold | ||||||||
5,250 | 4,721 | 4,170 | 3,697 | 3,339 | 3,667 | 2,882 | 2,391 | 1,934 |
Gross profit | ||||||||
13,683 | 13,913 | 12,856 | 11,231 | 9,427 | 7,803 | 6,732 | 5,376 | 3,772 |
Operating expenses: | ||||||||
Research and development | ||||||||
3,131 | 3,265 | 3,187 | 3,113 | 2,707 | 3,390 | 2,442 | 2,326 | 2,100 |
Selling, general and administrative | ||||||||
19,692 | 18,155 | 17,064 | 14,135 | 13,866 | 11,712 | 8,973 | 7,816 | 6,319 |
Total operating expenses | ||||||||
22,823 | 21,420 | 20,251 | 17,248 | 16,573 | 15,102 | 11,415 | 10,142 | 8,419 |
Loss from operations | ||||||||
-9,140 | -7,507 | -7,395 | -6,017 | -7,146 | -7,299 | -4,683 | -4,766 | -4,647 |
Interest income | ||||||||
404 | 441 | 565 | 598 | 52 | 124 | 28 | 24 | 13 |
Interest expense | ||||||||
1,202 | 1,217 | 1,176 | 1,207 | 1,352 | 1,296 | 1,065 | 1,011 | 989 |
Other income (expense), net | ||||||||
-3 | -8 | -1 | -5,333 | -15,712 | -7,147 | -3,233 | -1,898 | 215 |
Nett loss | ||||||||
- | - | -8,007 | - | - | - | -8,953 | - | - |
Comprehensive loss | ||||||||
- | - | -8,007 | - | - | - | -8,953 | - | - |
Net loss attributable to non-controlling interest | ||||||||
- | - | 0 | - | - | - | -1 | - | - |
Comprehensive loss attributable to non-controlling interest | ||||||||
- | - | 0 | - | - | - | -1 | - | - |
Net loss attributable to Silk Road Medical, Inc. common stockholders | ||||||||
-9,941 | -8,291 | -8,007 | -11,959 | -24,158 | -15,618 | -8,952 | -7,651 | -5,408 |
Other comprehensive loss: | ||||||||
Unrealized gains on investments, net | ||||||||
440 | - | - | - | 0 | - | - | - | - |
Net change in other comprehensive loss | ||||||||
440 | - | - | - | 0 | - | - | - | - |
Net loss and comprehensive loss | ||||||||
-9,501 | - | - | - | -24,158 | - | - | - | - |
Comprehensive loss attributable to Silk Road Medical, Inc. common stockholders | ||||||||
- | - | -8,007 | -11,959 | - | - | -8,952 | -7,651 | -5,408 |
Net loss per share, basic and diluted (in USD per share) | ||||||||
-0.32 | 18.52 | -0.26 | -0.42 | -20.12 | -15.20 | -8.49 | -8.16 | -7.31 |
Weighted average common shares used to compute net loss per share, basic and diluted (in shares) | ||||||||
31,338 | 31,402 | 30,764 | 28,458 | 1,200 | 1,111 | 1,054 | 938 | 739 |